Corgenix Engages Ascendiant Securities for Investment Banking Services DENVER, Jan. 18 /PRNewswire-FirstCall/ -- Corgenix Medical Corporation (OTC:CONX) (BULLETIN BOARD: CONX) today announced the engagement of Ascendiant Securities LLC, an investment banking firm based in Irvine, California. Ascendiant will explore various opportunities for the Company on a best efforts basis, including institutional private placement financing and potential joint ventures and strategic alliances. Corgenix has chosen Ascendiant after a comprehensive search within the investment banking community. In commenting about the new relationship, Douglass Simpson, Corgenix's president expressed his pleasure in joining forces with an investment banking firm that has a proven history of placing institutional investment capital in emerging companies such as ours. "We want to explore our capital needs with the institutional marketplace and, for a company such as Corgenix, management believes that Ascendiant can best leverage their base of institutional clients." Brad Wilhite, Co-Founder and Managing Director of Ascendiant Securities stated, "We have closely watched the development of Corgenix for the past 2 1/2 years and we are excited about the Company's outlook for growth, not only in its core business lines, but also in new product areas the Company is pursuing. We welcome Corgenix as our client and look forward to assisting the Company with its investment banking needs as we explore the various opportunities within their growing sector." About Corgenix Medical Corporation Corgenix is a leader in the development and manufacturing of anti-Phospholipid test kits, being the first on the market with an FDA cleared assay for anti-Cardiolipin (aCL). The Company is based in metropolitan Denver and is focused on the development of specialized diagnostic kits for immunology disorders, vascular diseases and bone and joint disorders. Corgenix diagnostic products are commercialized for use in clinical laboratories throughout the world. More information is available at http://www.corgenixonline.com/. About Ascendiant Securities LLC Ascendiant Securities LLC is a nationally ranked investment banking firm, registered as a broker-dealer with the Securities and Exchange Commission (SEC), and a member of the NASD and SIPC. Ascendiant provides investment banking and corporate finance services to its emerging public and private clients. These services include equity private placements of preferred and common stock, PIPEs (private investments in public equities), direct participation programs (investment limited partnerships), mezzanine financing, senior and subordinated debt financing, working capital facilities, convertible debt, and bridge financing. In December 2004, Ascendiant announced its ranking among the nation's top firms as recognized by Sagient Research Systems a leading publisher of independent research for the financial services and institutional investment communities. Out of 1,050 U.S. firms monitored by Sagient, Ascendiant Securities tied for 2nd among the most active placement agents for PIPE financings during the third quarter of 2004. PIPEs have become the funding vehicle of choice for many emerging technology companies in recent years. More information is available at http://www.ascendiant.com/. Statements in this press release that are not strictly historical facts are "forward looking" statements (identified by the words "believe", "estimate", "project", "expect" or similar expressions) within the meaning of the Private Securities Litigation Reform Act of 1995. These statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, failure to raise the necessary equity capital, continued acceptance of the Company's products and services in the marketplace, competitive factors, changes in the regulatory environment, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. The statements in this press release are made as of today, based upon information currently known to management, and the company does not undertake any obligation to publicly update or revise any forward-looking statements. Complete copies of the Corgenix Medical Corporation Forms 10-KSB and 10- QSB are available at http://www.sec.gov/. Copies and additional information can be obtained by contacting William Critchfield, Chief Financial Officer: phone (303) 453-8903, or e-mail at . DATASOURCE: Corgenix Medical Corporation CONTACT: William Critchfield, Chief Financial Officer of Corgenix Medical Corporation, +1-303-453-8903, Web site: http://www.ascendiant.com/ Web site: http://www.corgenix.com/

Copyright